Clinical Trials Logo

Clinical Trial Summary

A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02375633
Study type Interventional
Source Daewon Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 3
Start date April 2014

See also
  Status Clinical Trial Phase
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Recruiting NCT05220202 - MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression N/A
Completed NCT04571242 - SCS Programming Study in Treating Intractable Chronic Back Pain (NOVA) N/A
Active, not recruiting NCT05203770 - Adaptations of the Brain in Chronic Pain With Opioid Exposure I
Withdrawn NCT04082715 - Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity Phase 2
Completed NCT04307446 - Immersive Virtual Reality and Chronic Back Pain N/A
Completed NCT03896035 - Improving Outcomes for Older Veterans With Chronic Back Pain and Depression N/A
Recruiting NCT05994118 - Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports N/A
Active, not recruiting NCT03312010 - Tsunami DRG High Frequency Stimulation Study N/A
Recruiting NCT06453109 - Focused Ultrasound for the Complex Patient N/A
Completed NCT05167214 - The Acute Effect Of Different Kinesiological Tape N/A
Recruiting NCT06288282 - Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Recruiting NCT04270617 - The Effect of Yoga Practice on Chronic Back Pain N/A
Withdrawn NCT01631513 - An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) Phase 4
Completed NCT01766973 - Decoding Chronic Pain With fMRI
Recruiting NCT06406699 - Feasibility and Acceptability of Group Pain Reprocessing Therapy for Veterans With Chronic Neck/Back Pain N/A